Futures on the Dow were significantly worse than the S&P 500 because of a cardiovascular drug’s late-stage setback.
Related stories
Evercore appoints co-presidents as it sets up CEO succession contest
Macron faces political firestorm after riots
Trump to begin transforming historic golf course despite court order
US army chief in Asia calls for show of enhanced military muscle
US threatens Europe over Starlink restrictions
Trump’s bid to make America cheap again has failed